CAITLIN MORRIS: Open Payments
NPI 1932618238 · SANDUSKY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$744 in 25 payments from 17 companies in 2025. Trend: 2023 $676 · 2024 $839 · 2025 $744
Food & beverage: $540Education: $203
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 2 | $220 |
| Astellas Pharma US Inc | 1 | $95 |
| Gilead Sciences, Inc. | 3 | $69 |
| Merck Sharp & Dohme LLC | 3 | $61 |
| Lilly USA, LLC | 2 | $38 |
| Amgen Inc. | 2 | $35 |
| Janssen Biotech, Inc. | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Legend Biotech USA Inc. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: Jakafi, KEYTRUDA, OTEZLA, LYNOZYFIC, CARVYKTI, VERZENIO, Xofigo, Enhertu.
Industry payments across OH — which companies pay providers there.
